Sun Pharmaceutical Industries Limited (SUNPHARMA.NS) NSE
1,765.50
-24.4(-1.36%)
Currency In INR
- General
- Statistics
- Historical Data
- Profile
- Financials
1,765.50
-24.4(-1.36%)
Currency In INR
| Market Cap | 4.22T |
| Enterprise Value | 4.15T |
| P/E Ratio | 36.94 |
| PEG Ratio | 7.59 |
| Price/Sales Ratio | 7.25 |
| Price/Book Ratio | 5.07 |
| Enterprise/Revenue | 7.13 |
| Enterprise/EBITDA | 25.45 |
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.2 |
| Operating Margin | 0.23 |
| Return On Assets | 0.11 |
| Return On Equity | 0.15 |
| Revenue | 584.62B |
| Revenue/Share | 243.41 |
| Gross Profit | 325.62B |
| EBITDA | 164.91B |
| Net Income | 114.79B |
| Diluted EPS | 47.8 |
| Total Cash | 325.37B |
| Total Cash/Share | 135.47 |
| Total Debt | 45.96B |
| Total Debt/Equity | 0.05 |
| Current Ratio | 2.82 |
| Book Value Per Share | 349.24 |
| 52-Week Change | 5.88 |
| 52-Week High | 1,916.6 |
| 52-Week Low | 1,548 |
| Moving Average 50 Days | 1,773.7 |
| Moving Average 200 Days | 1,722.56 |
| Average Volume | 4.06M |
| Shares Outstanding | 2.4B |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 16.5 |
| Trailing Annual Dividend Yield | 0.93 |
| Payout Ratio | 0.11 |
| Last Split Factor | 2:1 |
| Last Split Date | July 29, 2013 |